appno,pubdate,pubnum,title,abstract,invs,assignee,xref,filedate,govint,parentcase,childcase,date371,pctpubno
13347116,20120607,20120137668,INCREASED POWER IN COMPRESSED-GAS ENERGY STORAGE AND RECOVERY,"In various embodiments, energy is stored or recovered via super-atmospheric compression and/or expansion of gas in conjunction with substantially adiabatic compression and/or expansion from or to atmospheric pressure.","","","This application claims the benefit of and priority to U.S. Provisional Patent Application No. 61/405,994, filed Oct. 22, 2010, and is a continuation-in-part of U.S. patent application Ser. No. 12/794,237, filed on Jun. 4, 2010, which claims the benefit of and priority to U.S. Provisional Patent Application Ser. Nos. 61/184,191, filed on Jun. 4, 2009; 61/222,286, filed on Jul. 1, 2009; 61/242,526, filed on Sep. 15, 2009; and 61/256,484, filed on Oct. 30, 2009. The entire disclosure of each of these references is hereby incorporated herein by reference.",20120110,This invention was made with government support under IIP-0923633 awarded by the NSF and DE-OE000231 awarded by the DOE. The government has certain rights in the invention.,13110142,13347116,"",""
13301773,20120607,20120138485,ORGANELLE BIOELECTRODES AND METHODS OF MAKING AND USING THE SAME,"A method for monitoring the metabolic state of an organelle in the presence of a potential organelle modulating agent is disclosed. A first organelle-modified bioelectrode is provided that is electrically coupled to a second electrode of opposite polarity in a circuit. The first bioelectrode is contacted with an aqueous carrier containing a biologically acceptable electrolyte and an effective amount of a potential organelle modulating agent and an effective amount of an organelle substrate. The substrate is reacted at the bioelectrode to form an ionic product that is released into the aqueous carrier-containing electrolyte to thereby provide a current at the second electrode when the circuit is closed. A metabolic flux data set is obtained during the reaction and is compared to a control metabolic flux data set obtained under the same conditions in the absence of the organelle modulating agent, thereby determining the metabolic state of the organelle.","",[SAINT LOUIS UNIVERSITY],"This application claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 61/417,123 filed Nov. 24, 2010 entitled Organelle Bioelectrodes And Methods Of Making And Using The Same, and further claims the benefit of U.S. Provisional Patent Application Ser. No. 61/514,432 filed Aug. 2, 2011 entitled Mitochondrial Bioelectrodes and Methods Of Making and Using The Same, the entirety of both of which are incorporated by reference herein in their entirety.",20111121,The present invention was made with governmental support pursuant to grants 3-02186 from the National Science Foundation and 3-00473 from the United States Air Force Office of Scientific Research. The government has certain rights in the invention.,"","","",""
13379740,20120607,20120138864,"NON-CRYSTALLINE MATERIALS HAVING COMPLETE PHOTONIC, ELECTRONIC, OR PHONONIC BAND GAPS","The invention provides an article of manufacture, and methods of designing and making the article. The article permits or prohibits waves of energy, especially photonic/electromagnetic energy, to propagate through it, depending on the energy band gaps built into it. The structure of the article may be reduced to a pattern of points having a hyperuniform distribution. The point-pattern may exhibit a crystalline symmetry, a quasicrystalline symmetry or may be aperiodic. In some embodiments, the point pattern exhibits no long-range order. Preferably, the point-pattern is isotropic. In all embodiments, the article has a complete, TE- and TM-optimized band-gap. The extraordinary transmission phenomena found in the disordered hyperuniform photonic structures of the invention find use in optical micro-circuitry (all-optical, electronic or thermal switching of the transmission), near-field optical probing, thermophotovoltaics, and energy-efficient incandescent sources.","","","",20100622,The research described in this application was supported by grant number DMR-0606415 from the National Science Foundation. The United States government has certain rights in the invention.,"","",20120215,PCT/US2010/039516
13383286,20120607,20120140302,"MEMS-BASED OPTICAL IMAGE SCANNING APPARATUS, METHODS, AND SYSTEMS","Disclosed are MEMS-based optical image scanners and methods for imaging using the same. According to one embodiment, a 3-D scanner for endoscopic imaging is provided, which includes a MEMS mirror for 1-D or 2-D lateral scanning and a MEMS lens for scanning along the optical axis to control the focal depth. The MEMS lens can be a microlens bonded to a MEMS holder. Both the MEMS holder and the MEMS mirror can be electrothermally actuated. A single-mode fiber can be used for both delivering the light to and receiving the returning light from an object being examined.","","[University of Florida Research Foundation, Incorpo]","This application claims the benefit of U.S. Provisional Application Ser. No. 61/239,619 filed Sep. 3, 2009, which is hereby incorporated by reference in its entirety, including all figures, tables and drawings.",20100826,The subject invention was made with government support under Grant Nos. 0423557 and 0818473 awarded by the National Science Foundation. The government has certain rights in the invention.,"","",20120110,PCT/US10/46775
11937787,20120607,20120140588,Fluidized Mixing And Blending of Nanopowders With Secondary Gas Flow,"Methods and systems for enhancing fluidization of nanoparticle and/or nanoagglomerates and for mixing and blending nanoparticle/nanoagglomerate systems at the nanoscale are provided. A fluidization chamber is provided with a fluidizing medium (e.g., a fluidizing gas) directed in a first fluidizing direction, e.g., upward into and through a bed containing a volume of nanoparticles and/or nanopowders. A second source of air/gas flow is provided with respect to the fluidization chamber, the secondary air/gas flow generally being oppositely (or substantially oppositely) directed relative to the fluidizing medium. Turbulence created by the secondary gas flow, e.g., a jet from a micro jet nozzle, is advantageously effective to aerate the agglomerates and the shear generated by the jet is advantageously effective to break apart nanoagglomerates and/or reduce the tendency for nanoagglomerates to form or reform. A downwardly directed source of secondary gas flow located near the main gas distributor leads to full fluidization of the entire amount of powder in the column. In addition, the oppositely directed fluid flow facilitates powder circulation within the fluidization chamber, thereby enhancing fluidization and mixing/blending results.","",[EVONIK DEGUSSA GMBH][NEW JERSEY INSTITUTE OF TECHNOLOGY],"The present application claims the benefit of a co-pending, provisional patent application entitled &#x201C;Fluidization System Enhanced by Micro-Jet Flow,&#x201D; which was filed on Nov. 10, 2006 and assigned Ser. No. 60/858,072. The entire content of the foregoing provisional patent application is incorporated herein by reference.",20071109,The work described in this patent disclosure was sponsored by the following Federal Agencies: National Science Foundation (NSF) Grant: NIRT DMI 0210400.,"","","",""
13114178,20120607,20120140807,SYSTEMS AND METHODS FOR MEASURING I-Q MISMATCH,"An exemplary embodiment of the present invention provides a method of measuring I-Q mismatch in a system having a transmitter. The transmitter comprises an in-phase up-converter, a quadrature-phase up-converter, and a power detector. The method of measuring I-Q mismatch comprises measuring an in-phase transmit power at the power detector caused by transmitting an in-phase output signal to the in-phase up-converter, measuring a quadrature-phase transmit power at the power detector caused by transmitting a quadrature-phase output signal to the quadrature-phase up-converter, calculating a transmitter-gain-mismatch as a function of the in-phase transmit power and the quadrature-phase transmit power, measuring an I-Q transmit power at the power detector caused by simultaneously transmitting a gain-mismatch-compensated in-phase output signal to the in-phase up-converter and a gain-mismatch-compensated quadrature-phase output signal to the quadrature-phase up-converter, and calculating a transmitter-phase-mismatch as a function of the I-Q transmit power.","",[Georgia Tech Research Corporation],"This application claims the benefit of U.S. Provisional Application Ser. No. 61/347,621, filed 24 May 2010, which is incorporated herein by reference in its entirety as if fully set forth below.",20110524,"The inventions described in this patent application were made with Government support under Agreement No. HR0011-10-3-0002, awarded by DARPA, and Agreement No. CCF-0916270, awarded by the National Science Foundation. The Government has certain rights in the invention described in this patent application.","","","",""
13310182,20120607,20120141032,SKETCH RECOGNITION SYSTEM,"Handwriting interpretation tools, such as optical character recognition (OCR), have improved over the years such that OCR is a common tool in business for interpreting typed text and sometimes handwritten text. OCR does not apply well to non-text-only diagrams, such as chemical structure diagrams. A method according to an embodiment of the present invention of interpreting a human-drawn sketch includes determining a local metric indicating whether a candidate symbol belongs to a certain classification based on a set of features. The set of features includes, as a feature, scores generated from feature images of the candidate symbol. Also included is determining a joint metric of multiple candidate symbols based on their respective classifications and interpreting the sketch as a function of the local and joint metrics. Sketches can be chemical composition, biological composition, electrical schematic, mechanical, or any other science- or engineering-based diagrams for which human-drawn symbols have well-known counterparts.","",[Massachusetts Institute of Technology],"This application claims the benefit of U.S. Provisional Application No. 61/459,065, filed on Dec. 3, 2010 and U.S. Provisional Application No. 61/467,268, filed on Mar. 24, 2011.The entire teachings of the above applications are incorporated herein by reference.",20111202,This invention was made with government support under Grant No. CMMI-0729422 awarded by the National Science Foundation. The government has certain rights in the invention.,"","","",""
12489820,20120607,20120141423,"NOVEL PAENIBACILLUS POLYMYXA STRAIN, ANTIBIOTIC ANTIMICROBIAL AGENTS AND METHODS OF THEIR USE","The present invention relates to a novel strain, OSY-DF, and its bioactive mutants. Also provided is a method for using a novel antimicrobial peptide, paenibacillin, isolated from the bacterial strain OSY-DF, and its bioactive variants or fragments. The invention also relates to antimicrobial compositions containing same and methods of their use.","","","This application claims priority to U.S. provisional application Nos. 60/827,397, filed Sep. 28, 2006, and 60/827,399, also filed, Sep. 28, 2006, the entire contents of which are incorporated herein by reference.",20090623,"This invention was made, in part, with government support from the National Science Foundation. The government may have certain rights in the invention.",12443609,12489820,"",""
13371260,20120607,20120141534,Vault Compositions for Immunization Against Chlamydia Genital Infection,"Methods and compositions are provided herein for immunizing a subject against Chlamydial genital infection by administering to the subject an effective amount of a Chlamydial immunogenic peptide or an immunogenic fragment or variant thereof incorporated within a vault-like particle carrier. In some aspects, the vault-like-particles are administered to the nasal mucosa. The methods and compositions advantageously exhibit enhanced ability to induce cell-mediated immunity and/or antibody-based immunity at mucosal surfaces while reducing inflammation associated with infection.","","","This application is a continuation of U.S. patent application Ser. No. 12/467,255, filed May 15, 2009, which claims the benefit of U.S. Provisional Application No. 61/053,623, filed May 15, 2008, each of which are herein incorporated by reference in their entirety.",20120210,This invention was made with United States Government support under National Institutes of Health Grant Nos. AI26328 AND EB004553 and National Science Foundation Grant No. MCB0210690. The United States Government has certain rights in this invention.,12467255,13371260,"",""
11972886,20120607,20120141543,Carbon Nanotube Based Nanocomposites,"Novel methods and compositions of nanocomposites are provided. One exemplary composition comprises a biocompatible polymer, such as polypropylene fumarate, and a carbon nanotube, such as a single walled carbon nanotube, an ultra-short carbon nanotube, or a substituted ultra-short carbon nanotube. An exemplary method comprises providing a biocompatible polymer and a carbon nanotube and combining a biocompatible polymer and a carbon nanotube to form a nanocomposite. Another exemplary method comprises providing a nanocomposite comprising a biocompatible polymer and a carbon nanotube and administering the composition to a subject.","","","This application claims the benefit of U.S. Provisional Application Ser. No. 60/884,582 filed Jan. 11, 2007, which is incorporated by reference.",20080111,"This invention was made with government support under Grant Number R01 AR42639, awarded by the National Institutes of Health, Grant Number EEC-0118001 awarded by the National Science Foundation, and Grant Number 0624 awarded by the Robert A. Welch Foundation. The U.S. government has certain rights in the invention.","","","",""
13370016,20120607,20120141558,ALGINATE-BASED NANOFIBERS AND RELATED SCAFFOLDS,"Alginate nanofibers, scaffolds that include alginate nanofibers, implantable devices that include alginate nanofibers, and methods for making the alginate nanofibers by electrospinning.","",[UNIVERSITY OF WASHINGTON],"This application is a division of U.S. patent application Ser. No. 12/239,478, filed Sep. 26, 2008, which is a continuation of International Application No. PCT/US2007/065388, filed Mar. 28, 2007, which claims the benefit of U.S. Provisional Application No. 60/787,099, filed Mar. 28, 2006. Each application is expressly incorporated herein by reference in its entirety.",20120209,"The invention was made with government support under Contract No. EEC 9529161, awarded by the National Science Foundation. The government has certain rights in the invention.",12239478,13370016,"",""
13316742,20120607,20120142042,Selective Delivery Of Molecules Into Cells Or Marking Of Cells In Diseased Tissue Regions Using Environmentally Sensitive Transmembrane Peptide,"A polypeptide with a predominantly hydrophobic sequence long enough to span a membrane lipid bilayer as a transmembrane helix (TM) and comprising one or more dissociable groups inserts across a membrane spontaneously in a pH-dependant fashion placing one terminus inside cell. The polypeptide conjugated with various functional moieties delivers and accumulates them at cell membrane with low extracellular pH. The functional moiety conjugated with polypeptide terminus placed inside cell are translocated through the cell membrane in cytosol. The peptide and its variants or non-peptide analogs can be used to deliver therapeutic, prophylactic, diagnostic, imaging, gene regulation, cell regulation, or immunologic agents to or inside of cells in vitro or in vivo in tissue at low extracellular pH.","",[Yale University],"This application claims the benefit of International Patent Application Serial No. PCT/US06/07881 filed on Jan. 18, 2006, which claims priority to U.S. Provisional Patent Application Ser. No. 60/752,238 filed on Dec. 20, 2005 and U.S. Provisional Patent Application Ser. No. 60/644,654 filed on Jan. 18, 2005, all of which are incorporated herein by reference in their entirety.",20111212,The United States government has rights in this invention by virtue of grant numbers GM 054160 from the National Institute of Health and 9905671 from the National Science Foundation.,11778323,13316742,"",""
13378440,20120607,20120142111,NANOMATERIAL-CONTAINING SIGNALING COMPOSITIONS FOR ASSAY OF FLOWING LIQUID STREAMS AND GEOLOGICAL FORMATIONS AND METHODS FOR USE THEREOF,"Compositions containing a transporter component and a signaling component and a method for using said compositions for analyzing porous media and flowing liquid streams, specifically for measuring pressure, temperature, relative abundance of water, pH, redox potential and electrolyte concentration. Analytes may include petroleum or other hydrophobic media, sulfur-containing compounds. The transporter component includes an amphiphilic nanomatenal and a plurality of solubilizing groups covalently bonded to the transporter component. The signaling component includes a plurality of reporter molecules associated with the transporter component. Said reporter molecules may be releasable from the transporter component upon exposure to at least one analyte. The reporter molecules may be non-covalently associated with the transporter component, or the reporter molecules are covalently bonded to the transporter component. Furthermore, said compositions and methods may be used to actively enhance oil recovery and for remediation of pollutants.","","","This application claims priority to U.S. Provisional Patent Application 61/187,971, filed Jun. 15, 2009, which is incorporated by reference in its entirety herein.",20100611,"This invention was made with Government support under grant number DE-FC-36-05GO15073 awarded by the United States Department of Energy, grant number W81XWH-08-2-0143 awarded by the United States Army, grant number 09-S568-064-01-C1 awarded by Universal Technology Corporation via pass-through funding from the Air Force Research Laboratory grant number FA8650-05-D-5807, and grant number EEC-0647452 awarded by the National Science Foundation. The invention was also made with Government support under grant number FA8650-07-2-5061 awarded by the Air Force Office of Scientific Research under the Air Force Research Laboratory Consortium for Nanomaterials for Aerospace Commerce and Technology (CONTACT). The Government has certain rights in the invention.","","",20120223,PCT/US10/38363
12984948,20120607,20120142547,POLYPEPTIDE IMMOBILIZATION,"The present invention provides a method, comprising (a) providing a reactant ligand attached to a substrate; (b) contacting the substrate with a fusion polypeptide, said fusion polypeptide comprising a capture polypeptide fused to a display polypeptide under conditions such that said reactant ligand covalently binds to said capture polypeptide; and (c) analyzing said display polypeptide.","",[],"The present application is a continuation of U.S. Ser. No. 11/645,095, filed Dec. 26, 2006 (pending), which is a continuation of U.S. Ser. No. 09/923,760, filed Aug. 7, 2001 (now U.S. Pat. No. 7,172,905).",20110204,The subject matter of this application was in part funded by the NSF (Grant nos. BES-9980850 and DMR9808595). The government may have certain rights in this invention.,11645095,12984948,"",""
13372234,20120607,20120142597,BIOMOLECULAR COATING FOR IMPLANTS,"Methods and compositions are provided for improving tissue growth and device integration in vivo. Substrates and devices coated with an αβor αβintegrin-specific ligand are provided. The substrates and devices coated with an αβor αβintegrin-specific ligand are shown to have greater tissue formation on the surface relative to controls, in particular greater bone formation.","",[],"This application is a divisional of U.S. Ser. No. 11/857,819 filed Sep. 19, 2006, which claims priority to U.S. Ser. No. 60/826,193 filed Sep. 19, 2006, both of which are incorporated herein by reference in their entirety.",20120213,"This invention was made with Government Support under Grant No. R01 EB-004496 by the National Institutes of Health, Grant No. DTD 000207 awarded by the Arthritis Foundation, and Grant No. ERC EEC-9731643 awarded by the National Science Foundation. The Government has certain rights in the invention.",11857819,13372234,"",""
13379801,20120607,20120142616,"Antineoplastic Hydrogels, and Enzyme-Instructed Preparations Thereof","Disclosed is a general methodology to create nano fibers of therapeutic molecules that have a dual role, as both the delivery vehicle and the drug itself. It is shown that with proper molecular design, the integration of enzymatic reaction and self-assembly provides a powerful method to create molecular hydrogels of clinically-used therapeutics without compromising their bioactivities. In addition, the results disclosed herein demonstrate enzyme-instructed self-assembly as a facile strategy for generating the supramolecular hydrogels of molecules that inherently have poor solubility in water. For example, by covalently connecting paclitaxel with a motif that is prone to self-assemble, a hydrogel of paclitaxel can be formed without compromising the activity of the paclitaxel.","","","This application claims the benefit of priority to U.S. Provisional Patent Application Ser. No. 61/220,657, filed Jun. 26, 2009; the entirety of which is hereby incorporated by reference.",20100624,"The invention was made with support provided by the National Science Foundation (Grant No. DMR 0820492); therefore, the United States government has certain rights in the invention.","","",20120216,PCT/US10/39789
12309143,20120607,20120142623,Compositions And Methods For Predicting Inhibitors Of Protein Targets,"Compositions and methods are provided for predicting inhibitors of protein targets related to treatment of infectious disease, for example, bacterial, viral, or parasitic diseases. Methods are provided for predicting inhibitors of protein targets related to treatment infectious disease, for example, microbial disease, utilizing a docking with dynamics protocol to identify inhibitors, or utilizing a protein structure energy function to identify peptide or peptidomimetic inhibitors.","","","This application claims the benefit of U.S. Provisional Application No. 60/819,426, filed Jul. 7, 2006, which is hereby incorporated by reference in its entirety.",20070706,"This invention was made by government support by Grant No. GM 068152 from National Institutes of Health, Grant Nos. DBI-0217241 and IIS 0448502 from the National Science Foundation. The Government has certain rights in this invention.","","",20090914,PCT/US2007/072985
13255542,20120607,20120143037,Accurate Pelvic Fracture Detection for X-Ray and CT Images,"Accurate pelvic fracture detection is accomplished with automated X-ray and Computed Tomography (CT) images for diagnosis and recommended therapy. The system combines computational methods to process images from two different modalities, using Active Shape Model (ASM), spline interpolation, active contours, and wavelet transform. By processing both X-ray and CT images, features which may be visible under one modality and not under the other are extracted and validates and confirms information visible in both. The X-ray component uses hierarchical approach based on directed Hough Transform to detect pelvic structures, removing the need for manual initialization. The X-ray component uses cubic spline interpolation to regulate ASM deformation during X-ray image segmentation. Key regions of the pelvis are first segmented and identified, allowing detection methods to be specialized to each structure using anatomical knowledge. The CT processing component is able to distinguish bone from other non-bone objects with similar visual characteristics, such a blood and contrast fluid, permitting detection and quantification of soft tissue hemorrhage. The CT processing component draws attention to slices where irregularities are detected, reducing the time to fully examine a pelvic CT scan. The quantitative measurement of bone displacement and hemorrhage area are used as input for a trauma decision-support system, along with physiological signals, injury details and demographic information.","","","",20100317,The U.S. Government has a paid-up license in this invention and the right in limited circumstances to require the patent owner to license on reasonable terms as provided for by the terms of Grant No. 05-0033-02 awarded by U.S. Medical Research and Material Command Combat Casualty Care Research Program and by the terms of NSF Grant No. IISO758410.,"","",20120220,PCT/US10/27601
13341149,20120607,20120143907,GENERATING AUDIO ANNOTATIONS FOR SEARCH AND RETRIEVAL,"Embodiments of a computer system to determine one or more annotation items associated with an audio file are described. During operation, the computer system provides an interactive environment in which multiple users listen to the audio file within a time interval. Next, the computer system receives one or more annotation items associated with the audio file from the multiple users. Then, the computer system displays the received one or more annotation items from the multiple users in the interactive environment, thereby enabling the multiple users to provide feedback to a given user in the multiple users.","",[THE REGENTS OF THE UNIVERSITY OF CALIFORNIA],"This application is a continuation of, and hereby claims priority under 35 U.S.C. &#xA7;120 to, pending U.S. patent application Ser. No. 12/052,299, entitled &#x201C;Generating Audio Annotations for Search and Retrieval,&#x201D; by the same inventors filed on 20 Mar. 2008 (Attorney Docket No. UCSD2007-0180). U.S. patent application Ser. No. 12/052,299 claims priority under 35 U.S.C. 119(e) to U.S. Provisional Application Ser. No. 60/896,216, &#x201C;Generating Audio Annotations for Search and Retrieval,&#x201D; filed on 21 Mar. 2007, the contents of which are herein incorporated by reference.",20111230,This invention was made with United States Government support under Grant No. DGE-0333451 and Grant No. DMS-MSPA-062540922 awarded by the National Science Foundation. The United States Government has certain rights in the invention.,12052299,13341149,"",""
13312844,20120607,20120144372,SYSTEMS AND METHODS FOR FINDING CONCURRENCY ERRORS,"Systems and methods for detecting concurrency bugs are provided. In some embodiments, context-aware communication graphs that represent inter-thread communication are collected during test runs, and may be labeled according to whether the test run was correct or failed. Graph edges that are likely to be associated with failed behavior are determined, and probable reconstructions of failed behavior are constructed to assist in debugging. In some embodiments, software instrumentation is used to collect the communication graphs. In some embodiments, hardware configured to collect the communication graphs is provided.","",[University of Washington through its Center for Commercialization],"This application claims the benefit of U.S. Provisional Application No. 61/420,185, filed Dec. 6, 2010, which is incorporated herein by reference in its entirety for all purposes.",20111206,"This invention was made with government support under CNS-0720593 and CCF-0930512, awarded by the National Science Foundation. The government has certain rights in the invention.","","","",""
13372911,20120607,20120144525,Engineering Single-Gene-Controlled Staygreen Potential Into Plants,"The enzymes of the ACC synthase family are used in producing ethylene. Nucleotide and polypeptide sequences of ACC synthases are provided along with knockout plant cells having inhibition in expression and/or activity in an ACC synthase and knockout plants displaying a staygreen phenotype, a male sterility phenotype, or an inhibition in ethylene production. Methods for modulating staygreen potential in plants, methods for modulating sterility in plants, and methods for inhibiting ethylene production in plants are also provided.","","[The Regents of the University of California][Pioneer Hi-Bred International, Inc.]","This application is a continuation of U.S. patent application Ser. No. 12/800,466, filed May 14, 2010, entitled &#x201C;Engineering single-gene-controlled staygreen potential into plants&#x201D; by Gallie et al., which is a divisional of U.S. patent application Ser. No. 11/698,310, filed Jan. 24, 2007, entitled &#x201C;Engineering single-gene-controlled staygreen potential into plants&#x201D; by Gallie et al., which issued on Jul. 27, 2010 as U.S. Pat. No. 7,763,773, entitled &#x201C;Engineering single-gene-controlled staygreen potential into plants,&#x201D; and which is a continuation of U.S. patent application Ser. No. 10/875,127, filed Jun. 22, 2004, entitled &#x201C;Engineering single-gene-controlled staygreen potential into plants&#x201D; by Gallie et al., which issued on Jun. 12, 2007 as U.S. Pat. No. 7,230,161, entitled &#x201C;Engineering single-gene-controlled staygreen potential into plants utilizing ACC synthase from maize,&#x201D; and which claims priority to and benefit of the following prior provisional patent application: U.S. Ser. No. 60/480,861, filed Jun. 23, 2003, entitled &#x201C;Engineering single-gene-controlled staygreen potential into plants&#x201D; by Gallie et al. Each of these applications is incorporated herein by reference in its entirety for all purposes.",20120214,This invention was made with government support under grants 97-35304-4657 and 98-35100-6150 awarded by the United States Department of Agriculture and grant 0076434 awarded by the National Science Foundation. The government has certain rights in the invention.,12800466,13372911,"",""
